Skip to content

Blog

Two key drugs for drug resistant TB are now essential medicines. But will patients benefit?

An increase in multidrug-resistant tuberculosis cases is being seen worldwide. Its management involves complex treatment, high costs, more toxic anti-tuberculosis drug use, longer treatment time and increased treatment failure and mortality. In India, access to key drugs is an added… Read More »Two key drugs for drug resistant TB are now essential medicines. But will patients benefit?

en_USEnglish